Ms. Doriskay Monroe Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 156 State Route 15, Lafayette, NJ 07848 Phone: 973-862-6377 |
Shauna Menzella, DPT Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 156 State Route 15, Lafayette, NJ 07848 Phone: 973-862-6377 |
Tara Austine Perretta, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 73 Mulford Rd., Andover Subacute And Rehab, Lafayette, NJ 07848 Phone: 973-383-6200 |
Anne Marie Collum, PT, DPT Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 156 State Route 15, Lafayette, NJ 07848 Phone: 973-862-6377 |
Damon Physical Therapy Physical Therapist - Orthopedic Medicare: Medicare Enrolled Practice Location: 156 State Route 15, Lafayette, NJ 07848 Phone: 973-862-6377 Fax: 973-862-6379 |
Jessica Takacs Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 49 Mulford Rd, Lafayette, NJ 07848 Phone: 862-268-5800 |
Kennedy Amber Young Physical Therapist - Pediatrics Medicare: Medicare Enrolled Practice Location: 156 Nj-15 N, Lafayette, NJ 07848 Phone: 646-841-1400 |
Angelique Donati, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 156 State Route 15, Lafayette, NJ 07848 Phone: 973-862-6377 |
News Archive
A team of Syracuse University researchers discovered a second molecular switch within the Mixed Lineage Leukemia protein complex that they believe could be exploited to prevent the overproduction of abnormal cells that are found in several types of cancer, including leukemia.
Could bile acids-the fat-dissolving juices churned out by the liver and gallbladder-also play a role in immunity and inflammation?
Most breast cancer surgeons' practices do not follow standards associated with the best quality of care, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has accepted for review the complete response submission made by Endo to the new drug application for its long-acting testosterone undecanoate injection, AVEED, intended for men diagnosed with hypogonadism.
› Verified 4 days ago